https://www.selleckchem.com/pr....oducts/forskolin.htm
Both tacrolimus (TAC) and fentanyl are frequently used in patients receiving allogeneic hematopoietic stem cell transplantation (HSCT). A recently published report demonstrated that fentanyl can reduce the total body clearance of TAC; however, most patients in this study were administered concomitantly with azole antifungal agents, which are known to be strong inhibitors of CYP3A. Hence, the exact effect of fentanyl on TAC pharmacokinetics was unclear. In the current study, the authors retrospectively investigated the pharmacokinetic